ESR1 and breast cancer: Recent studies have shown that chronic estrogen deprivation in ER‐positive breast cancer cells resulted in epigenetic activation of the mevalonate pathway and accumulation of other ligands, including 27HC, which potentiates ER signaling even in the absence of estrogen.30, 31